Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (July 2022)

BACKGROUND: Coronavirus disease (COVID‐19), an infectious disease caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has spread worldwide since early 2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines for the Managem...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamakawa, Kazuma, Yamamoto, Ryo, Terayama, Takero, Hashimoto, Hideki, Ishihara, Tadashi, Ishimaru, Go, Imura, Haruki, Okano, Hiromu, Narita, Chihiro, Mayumi, Takuya, Yasuda, Hideto, Yamada, Kohei, Yamada, Hiroyuki, Kawasaki, Tatsuya, Shime, Nobuaki, Doi, Kent, Egi, Moritoki, Ogura, Hiroshi, Aihara, Morio, Kushimoto, Shigeki, Nishida, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579991/
https://www.ncbi.nlm.nih.gov/pubmed/36267628
http://dx.doi.org/10.1002/ams2.789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579991/
https://www.ncbi.nlm.nih.gov/pubmed/36267628
http://dx.doi.org/10.1002/ams2.789

Ejemplares similares